The Latino Alzheimer's and Memory Disorders Alliance (LAMDA) will expand community health worker services to support quality of life for persons with Alzheimer's disease and related dementias, through a $2 million cooperative agreement from the Administration for Community Living within the U.S. Department of Health and Human Services. The funding will support LAMDA's CHW Expansion Project from September 2022 through August 2025. The project aims to develop and expand the availability of...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $311,341 to the University of Southern California to assess cost and non-cost barriers to the use of novel Alzheimer's disease (AD) and related dementia (ADRD) therapeutics among older Hispanic or Latino adults. The project involves two main phases. The first phase will conduct semi-structured interviews with a cohort of Latino adults and Latino patients with AD/ADRD and their caregivers to...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $956,214 will fund Ceresti Health, Inc. to develop and validate a Spanish-language version of their Caregiver-Enabled Care Program (CECP) for Hispanic/Latino families caring for loved ones with dementia. The CECP is a digital population health intervention that provides personalized education, coaching, and remote monitoring to unpaid/informal caregivers via a dedicated tablet. This project aims...
This $767,193 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to identify undiagnosed Alzheimer's disease (AD) in underserved Hispanic/Latino and African American populations. The key products and services to be delivered under this award include: Identifying disease trajectories associated with AD to help predict undiagnosed cases, while accounting for underdiagnosis bias in the target populations (Aims 1-2). Integrating...
This $1,010,230 Project Grant award, funded by the National Institute on Aging (CFDA 93.866 Aging Research), supports research to evaluate the feasibility and effectiveness of a culturally-adapted mindfulness-based program (MBP) for Latinx older adults at risk of developing Alzheimer's disease (AD). The Washington University is leading this R61 research project, which aims to address disparities in AD burden among Latinx communities through a new MBP intervention tailored to their specific...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $499,796 to Clear Session, Inc. to develop an innovative digital visualization tool to improve communication between clinicians, Latino Alzheimer's disease and related dementias (ADRD) patients, and their caregivers. The tool is designed to be linguistically and culturally tailored to break down complex medical information in a clear and comprehensible way, thereby enhancing healthcare...
This Project Grant award for $774,997, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), will support a randomized clinical trial to assess the efficacy of the CUIDATEXT text message intervention to provide caregiver support for Latino families caring for individuals with Alzheimer's disease and related dementias. The intervention, developed using user-centered principles, delivers tailored daily text messages covering five domains: disease education,...
The New Mexico Aging and Long Term Services Department will receive $1.5 million through a three-year cooperative agreement award from the U.S. Department of Health and Human Services Administration for Community Living under the Alzheimer's Disease Program Initiative. The purpose of this funding is to support the development of a dementia-capable ecosystem of home and community-based services in New Mexico. Specifically, the Department will work to expand availability of supports and services...
The Department of Health and Human Services Administration for Community Living awarded a $1,000,000 cooperative agreement to Alzheimers Greater LOS Angeles under the Alzheimer's Disease Program Initiative (ADPI) from July 1, 2021 to June 30, 2024. The purpose of the ADPI program is to develop and expand dementia-capable supports and services for persons with Alzheimer's disease and related dementias at the state and community levels. Under this award, Alzheimers Greater LOS Angeles will work to...
The National Institute on Aging (NIA) has awarded a $856,580 Project Grant (CFDA 93.866 - Aging Research) to the University of Massachusetts Lowell to elucidate the role of the gut microbiome in Alzheimer's disease and related dementias (AD/ADRD) among the Latino population. The 5-year project will leverage the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) cohort to collect longitudinal gut microbiome and metabolomic data from approximately 2,800 participants across field centers...